Stock MD PEDIATRIX MEDICAL GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pediatrix Medical Group, Inc.

Equities

MD

US58502B1061

Healthcare Facilities & Services

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
9.04 USD +1.57% Intraday chart for Pediatrix Medical Group, Inc. +0.11% -2.80%
Mar. 06 Jefferies Cuts Price Target on Pediatrix Medical to $9 From $11, Maintains Hold Rating MT
Feb. 21 Deutsche Bank Trims Pediatrix Medical Group Price Target to $8 From $9, Maintains Sell Rating MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,306 2,058 2,319 1,217 770.3 747.3 - -
Enterprise Value (EV) 1 3,924 2,679 2,937 1,859 1,330 1,200 1,134 1,070
P/E ratio -1.55 x -2.57 x 17.8 x 18.8 x -12.7 x 8.49 x 8.26 x 8.57 x
Yield - - - - - - - -
Capitalization / Revenue 0.66 x 1.19 x 1.21 x 0.62 x 0.39 x 0.37 x 0.35 x 0.34 x
EV / Revenue 1.12 x 1.55 x 1.54 x 0.94 x 0.67 x 0.59 x 0.54 x 0.49 x
EV / EBITDA 7.84 x 12.2 x 11.1 x 7.71 x 6.64 x 5.98 x 5.49 x 5.09 x
EV / FCF 12.5 x 15.2 x 66 x - 12.8 x 11.6 x 10.5 x -
FCF Yield 8.02% 6.56% 1.51% - 7.82% 8.59% 9.53% -
Price to Book 1.56 x 2.81 x 2.62 x 1.38 x 0.92 x 0.8 x 0.73 x 0.68 x
Nbr of stocks (in thousands) 82,988 83,875 85,241 81,926 82,829 82,669 - -
Reference price 2 27.79 24.54 27.21 14.86 9.300 9.040 9.040 9.040
Announcement Date 2/20/20 2/18/21 2/17/22 2/17/23 2/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,514 1,734 1,911 1,972 1,995 2,046 2,108 2,197
EBITDA 1 500.8 219.9 265.5 241 200.4 200.8 206.6 210.3
EBIT 1 408.5 191.4 233.3 205.4 164.2 166.3 169.6 176.2
Operating Margin 11.63% 11.04% 12.21% 10.42% 8.23% 8.12% 8.05% 8.02%
Earnings before Tax (EBT) 1 -1,242 7.148 135.2 81.37 -48.36 125.1 131.1 136.9
Net income 1 -1,498 -796.5 131 66.34 -60.41 86.77 89.21 69.7
Net margin -42.63% -45.93% 6.85% 3.36% -3.03% 4.24% 4.23% 3.17%
EPS 2 -17.94 -9.550 1.530 0.7900 -0.7300 1.065 1.095 1.055
Free Cash Flow 1 314.8 175.8 44.49 - 104 103 108.1 -
FCF margin 8.96% 10.14% 2.33% - 5.21% 5.03% 5.13% -
FCF Conversion (EBITDA) 62.85% 79.97% 16.76% - 51.89% 51.32% 52.31% -
FCF Conversion (Net income) - - 33.97% - - 118.73% 121.17% -
Dividend per Share 2 - - - - - - - -
Announcement Date 2/20/20 2/18/21 2/17/22 2/17/23 2/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 492.9 498.5 482.2 486 489.9 513.8 491 500.6 506.6 496.4 500.4 510.4 519.4 516.4 518.5
EBITDA 1 73.42 81.04 50.68 65.56 58.31 66.49 40.06 59.12 50.42 50.82 36.4 55.04 54.33 54.98 38.21
EBIT 1 65.27 73.18 41.91 56.78 49.35 57.35 31.1 50.18 40.27 41.76 27.02 45 47.09 47.16 29.39
Operating Margin 13.24% 14.68% 8.69% 11.68% 10.07% 11.16% 6.33% 10.02% 7.95% 8.41% 5.4% 8.82% 9.07% 9.13% 5.67%
Earnings before Tax (EBT) 1 43.43 53.52 -28.35 43.03 38.86 27.82 20.71 38.95 30.83 -138.8 17.07 35.54 34.56 36.01 19.94
Net income 1 30.8 47.52 -21.19 27.14 30.73 29.66 14.21 28.28 21.39 -124.3 12.07 25.52 23.01 26.18 12.95
Net margin 6.25% 9.53% -4.39% 5.58% 6.27% 5.77% 2.89% 5.65% 4.22% -25.04% 2.41% 5% 4.43% 5.07% 2.5%
EPS 2 0.3600 0.5500 -0.2500 0.3200 0.3700 0.3600 0.1700 0.3400 0.2600 -1.500 0.1475 0.3125 0.2850 0.3225 0.1550
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 10/28/21 2/17/22 4/28/22 8/4/22 11/3/22 2/17/23 5/2/23 8/3/23 11/2/23 2/20/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,618 621 617 641 560 452 387 322
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.23 x 2.824 x 2.325 x 2.661 x 2.795 x 2.253 x 1.871 x 1.533 x
Free Cash Flow 1 315 176 44.5 - 104 103 108 -
ROE (net income / shareholders' equity) 12.3% 7.04% 15.9% 15.7% 11.9% 11.5% 11.2% 10.5%
ROA (Net income/ Total Assets) 5.6% 2.11% 7.08% 5.52% 4.54% 4.7% 4.84% 5.09%
Assets 1 -26,758 -37,759 1,850 1,202 -1,332 1,847 1,844 1,370
Book Value Per Share 2 17.80 8.730 10.40 10.70 10.10 11.30 12.30 13.30
Cash Flow per Share 2 4.150 2.450 0.8900 - 1.670 1.590 1.900 1.970
Capex 1 31.9 28.8 32.2 - 33.3 30.4 31.4 30.9
Capex / Sales 0.91% 1.66% 1.69% - 1.67% 1.49% 1.49% 1.41%
Announcement Date 2/20/20 2/18/21 2/17/22 2/17/23 2/20/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Pediatrix Medical Group, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
9.04 USD
Average target price
9.071 USD
Spread / Average Target
+0.35%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
PEDIATRIX MEDICAL GROUP, INC. Stock Pediatrix Medical Group, Inc.
-2.80% 747M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-3.97% 11.66B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. MD Stock
  4. Financials Pediatrix Medical Group, Inc.